FDA NDC Directory · JSON-LD · Markdown

TROGARZO

NDC 62064-122 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameibalizumab
Labeler / ManufacturerTheratechnologies Inc.
Marketing categoryBiologic License Application · App BLA761065
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsIBALIZUMAB (150 mg/mL)
Marketing started20180420
Package count1

External sources

Source: openFDA. Public-domain (CC0).